BR9914893A - Cromenona e derivados de cromanona como inibidores de integrina - Google Patents
Cromenona e derivados de cromanona como inibidores de integrinaInfo
- Publication number
- BR9914893A BR9914893A BR9914893-5A BR9914893A BR9914893A BR 9914893 A BR9914893 A BR 9914893A BR 9914893 A BR9914893 A BR 9914893A BR 9914893 A BR9914893 A BR 9914893A
- Authority
- BR
- Brazil
- Prior art keywords
- integrin inhibitors
- chromenone
- chromanone derivatives
- chromanone
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Patente de Invenção: <B>"CROMENONA E DERIVADOS DE CROMANONA COMO INIBIDORES DE INTEGRINA"<D>. A invenção refere-se a compostos tendo a fórmula (I) em que R¹, R², R³, R^ 4^, R^ 5^, R^ 6^, R^ 8^, R^ 11^, Z, m e n possuem o significado citado na reivindicação 1 e seus sais e solvatos fisiologicamente aceitáveis, os quais podem ser usados como inibidores da integrina, especialmente na profilaxia e tratamento de doenças circulatórias, no caso de trombose, enfarte do miocárdio, doenças cardíacas coronarianas, arteriosclerose, osteoporose, processos patológicos causados ou propagados por angiogênese e na terapia de tumores.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19850131A DE19850131A1 (de) | 1998-10-30 | 1998-10-30 | Chromenon- und Chromanonderivate |
PCT/EP1999/007725 WO2000026212A1 (de) | 1998-10-30 | 1999-10-14 | Chromenon- und chromanonderivate als integrinhemmer |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9914893A true BR9914893A (pt) | 2001-07-17 |
Family
ID=7886203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9914893-5A BR9914893A (pt) | 1998-10-30 | 1999-10-14 | Cromenona e derivados de cromanona como inibidores de integrina |
Country Status (21)
Country | Link |
---|---|
US (1) | US6849646B1 (pt) |
EP (1) | EP1124824B1 (pt) |
JP (1) | JP4511734B2 (pt) |
KR (1) | KR20010080896A (pt) |
CN (1) | CN1150189C (pt) |
AR (1) | AR021029A1 (pt) |
AT (1) | ATE370944T1 (pt) |
AU (1) | AU754280B2 (pt) |
BR (1) | BR9914893A (pt) |
CA (1) | CA2348391C (pt) |
CZ (1) | CZ20011515A3 (pt) |
DE (2) | DE19850131A1 (pt) |
ES (1) | ES2292252T3 (pt) |
HU (1) | HUP0104800A3 (pt) |
ID (1) | ID28482A (pt) |
NO (1) | NO20012108D0 (pt) |
PL (1) | PL347246A1 (pt) |
RU (1) | RU2234505C2 (pt) |
SK (1) | SK5532001A3 (pt) |
WO (1) | WO2000026212A1 (pt) |
ZA (1) | ZA200104411B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19842415A1 (de) | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
BR0115077A (pt) * | 2000-11-01 | 2003-12-23 | Merck Patent Ges Mit Beschroen | Métodos e composições para o tratamento de doenças dos olhos |
CA2449054C (en) | 2001-05-30 | 2011-01-04 | The Scripps Research Institute | Integrin targeting liposome for nucleic acid delivery |
BR0211604A (pt) * | 2001-08-01 | 2004-08-24 | Merck Patent Gmbh | Inibidores de integrina para o tratamento de doenças do olho |
KR20040091002A (ko) * | 2002-02-14 | 2004-10-27 | 메르크 파텐트 게엠베하 | 안질환을 치료하기 위한 방법 및 조성물 |
JP4664597B2 (ja) | 2002-04-17 | 2011-04-06 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
US20060122387A1 (en) * | 2002-06-13 | 2006-06-08 | Cti Europe S.R.L. | Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
FR2841243B1 (fr) * | 2002-06-19 | 2004-08-20 | Servier Lab | Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU2003252025A1 (en) | 2002-07-17 | 2004-02-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
DE10337863A1 (de) | 2003-08-18 | 2005-03-17 | Merck Patent Gmbh | Verwendung von Chromen-4-on-Derivaten |
DK2307397T3 (da) * | 2008-06-25 | 2014-11-03 | Array Biopharma Inc | 6-substituerede phenoxychroman-carboxylsyrederivater |
WO2011156889A1 (en) * | 2010-06-14 | 2011-12-22 | Trt Pharma Inc. | Novel modulators of nrf2 and uses thereof |
RU2612875C1 (ru) * | 2015-12-14 | 2017-03-13 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | Средство для ингибирования фермента тирозил-днк-фосфодиэстеразы 1 человека |
CN112110902B (zh) * | 2020-09-17 | 2021-12-07 | 江苏科技大学 | 1-脱氧野尻霉素-山奈酚化合物、中间体,制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89840A (en) * | 1988-04-06 | 1996-10-31 | Lipha | Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them |
EP0459983A1 (en) * | 1988-12-21 | 1991-12-11 | PHARMACIA & UPJOHN COMPANY | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
US5703075A (en) | 1988-12-21 | 1997-12-30 | Pharmacia & Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
WO1991019707A2 (en) * | 1990-06-20 | 1991-12-26 | The Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
FR2693196B1 (fr) * | 1992-07-03 | 1994-12-23 | Lipha | Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant. |
US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
FR2717479B1 (fr) * | 1994-03-18 | 1996-06-07 | Pf Medicament | Nouvelles 3-(omega-benzoylpipéridino) alcoyl)-4H-Benzopyran-4-ones, leur préparation et leur application en thérapeutique. |
-
1998
- 1998-10-30 DE DE19850131A patent/DE19850131A1/de not_active Withdrawn
-
1999
- 1999-10-14 DE DE59914471T patent/DE59914471D1/de not_active Expired - Lifetime
- 1999-10-14 WO PCT/EP1999/007725 patent/WO2000026212A1/de active IP Right Grant
- 1999-10-14 US US09/830,285 patent/US6849646B1/en not_active Expired - Fee Related
- 1999-10-14 KR KR1020017005079A patent/KR20010080896A/ko not_active Application Discontinuation
- 1999-10-14 RU RU2001114188/04A patent/RU2234505C2/ru not_active IP Right Cessation
- 1999-10-14 HU HU0104800A patent/HUP0104800A3/hu unknown
- 1999-10-14 PL PL99347246A patent/PL347246A1/xx unknown
- 1999-10-14 ID IDW00200101018A patent/ID28482A/id unknown
- 1999-10-14 EP EP99952566A patent/EP1124824B1/de not_active Expired - Lifetime
- 1999-10-14 CN CNB998142344A patent/CN1150189C/zh not_active Expired - Fee Related
- 1999-10-14 AU AU64716/99A patent/AU754280B2/en not_active Ceased
- 1999-10-14 AT AT99952566T patent/ATE370944T1/de not_active IP Right Cessation
- 1999-10-14 SK SK553-2001A patent/SK5532001A3/sk unknown
- 1999-10-14 CZ CZ20011515A patent/CZ20011515A3/cs unknown
- 1999-10-14 CA CA002348391A patent/CA2348391C/en not_active Expired - Fee Related
- 1999-10-14 BR BR9914893-5A patent/BR9914893A/pt not_active IP Right Cessation
- 1999-10-14 ES ES99952566T patent/ES2292252T3/es not_active Expired - Lifetime
- 1999-10-14 JP JP2000579600A patent/JP4511734B2/ja not_active Expired - Fee Related
- 1999-10-29 AR ARP990105483A patent/AR021029A1/es not_active Application Discontinuation
-
2001
- 2001-04-27 NO NO20012108A patent/NO20012108D0/no not_active Application Discontinuation
- 2001-05-29 ZA ZA200104411A patent/ZA200104411B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2234505C2 (ru) | 2004-08-20 |
EP1124824B1 (de) | 2007-08-22 |
DE19850131A1 (de) | 2000-05-04 |
DE59914471D1 (de) | 2007-10-04 |
NO20012108L (no) | 2001-04-27 |
HUP0104800A2 (hu) | 2002-07-29 |
HUP0104800A3 (en) | 2003-12-29 |
NO20012108D0 (no) | 2001-04-27 |
CA2348391C (en) | 2009-09-29 |
CZ20011515A3 (cs) | 2001-08-15 |
AR021029A1 (es) | 2002-06-12 |
ATE370944T1 (de) | 2007-09-15 |
EP1124824A1 (de) | 2001-08-22 |
JP4511734B2 (ja) | 2010-07-28 |
PL347246A1 (en) | 2002-03-25 |
AU6471699A (en) | 2000-05-22 |
SK5532001A3 (en) | 2001-12-03 |
CN1329610A (zh) | 2002-01-02 |
ES2292252T3 (es) | 2008-03-01 |
CA2348391A1 (en) | 2000-05-11 |
ID28482A (id) | 2001-05-31 |
US6849646B1 (en) | 2005-02-01 |
CN1150189C (zh) | 2004-05-19 |
WO2000026212A1 (de) | 2000-05-11 |
KR20010080896A (ko) | 2001-08-25 |
JP2002528544A (ja) | 2002-09-03 |
ZA200104411B (en) | 2002-08-29 |
AU754280B2 (en) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9912072A (pt) | Derivados diacil-hidrazina | |
BR9914893A (pt) | Cromenona e derivados de cromanona como inibidores de integrina | |
TW372232B (en) | Phenylalanine derivatives | |
DK0939627T3 (da) | Pentaflourbenzensulfonamider og analoger | |
BR9807345A (pt) | Aminoácidos aromáticos biciclicos. | |
BR0313732A (pt) | Compostos de pirimido tendo atividade antiproliferativa | |
BR0012896A (pt) | 2-pirazolin-5-onas | |
BR0203644A (pt) | Derivados heteroarìlicos dissubstituìdos com ácido como inibidores de metaloproteinase de matriz | |
BR0101264A (pt) | Derivados de diazepan ou seus sais | |
AR027398A1 (es) | Derivados de indol-3-ilo | |
MY133897A (en) | N-(4-carb-amimidophenyl) glycineamide derivatives | |
BR0008310A (pt) | Derivados de alfa-alanina | |
BR9910032A (pt) | Tienopirimidinas | |
BR0213037A (pt) | Derivados de pirimidina | |
BR0011778A (pt) | Tienopirimidinas | |
NO20023486L (no) | Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer | |
BR0116372A (pt) | Composto, composição farmacêutica e método de tratamento ou de prevenção de uma doença | |
BR0116202A (pt) | Derivados de uréia e uretano como inibidores de integrinas | |
BR0008437A (pt) | Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos | |
BR0308195A (pt) | Derivados de isoquinolina | |
BR9813719A (pt) | Agentes terapêuticos | |
BR0015333A (pt) | Derivados de isoxazol como inibidores de fosfodiesterase vii | |
BR0113374A (pt) | Derivados de bifenila e seu uso como inibidores da integrina | |
NO20000016L (no) | Sykliske azapeptider med angiogen virkning | |
BR0013083A (pt) | Derivados de fluorano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |